Dec
2026
Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia
Visit us
stand H1.S10

Dar Aldawa Development & Investment Co

Exhibitor at CPHI Middle East 2026
About Us

Established nearly five decades ago, Dar Aldawa was founded to enhance access to reliable, safe, and effective medicines. It rapidly evolved into a prominent regional pharmaceutical company, delivering high-quality pharmaceutical and consumer healthcare products through integrated development, manufacturing, and distribution capabilities. With operations spanning the Middle East, North Africa, and Europe, Dar Aldawa continues to uphold excellence in quality and strives to be a trusted partner in advancing healthcare outcomes and supporting patients and caregivers globally.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Saudi Arabia
  • On CPHI since:
    2025
  • Employees:
    1000 - 4999
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Middle East 2026
  • 14 Dec 2026 - 16 Dec 2026
  • Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia
  • Visit us at stand H1.S10

Products Featured at CPHI Middle East 2026

  • Clavodar®

    Product Clavodar®

    Clavodar® is an antibiotic and works by killing bacteria that cause infections. It contains two different medicines called amoxicillin and clavulanic acid. Amoxicillin belongs to a group of medicines called “penicillins” that can sometimes be stopped from working (made inactive). The other active component...
  • Gamcet®

    Product Gamcet®

    The active ingredient in Gamcet® tablets is tamsulosin. This is a selective alpha1A/1D adrenoceptor antagonist. It reduces tension of the smooth muscles in the prostate and the urethra, enabling urine to pass more readily through the urethra and facilitating urination. In addition, it dimini...
  • Hairgrow®

    Product Hairgrow®

    Hairgrow® is a medicine used to treat common hereditary hair loss in adults aged 18-65 years, by preventing further hair loss and helping hair re-growth.

    It contains minoxidil which is thought to work by aiding the blood flow to the hair follicles on your scalp.

    Strength:
    ...
  • Rina® Extra

    Product Rina® Extra

    Rina® Extra extended release tablets is a prescription medicine that contains the medicines Desloratadine (an antihistamine) and Pseudoephedrine (a nasal decongestant). Rina® Extra is used to help control the symptoms of seasonal allergic rhinitis (sneezing, stuffy nose, runny nose...

Dar Al Dawa Regional Headquarters Resources (1)